Renaissance Technologies (RenTech)'s LUNG Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 320,300 shares of Pulmonx Corporation (LUNG) worth $413,187, representing 0.00% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in LUNG, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 176,803 shares. Largest reduction occurred in Q3 2024, reducing 142,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Pulmonx Corporation (LUNG) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pulmonx Corporation (LUNG) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +28,300 | Add 9.69% | 320,300 | $1.29 |
| Q4 2025 | -40,810 | Reduce 12.26% | 292,000 | $2.21 |
| Q3 2025 | +81,500 | Add 32.43% | 332,810 | $1.62 |
| Q2 2025 | +86,010 | Add 52.03% | 251,310 | $2.59 |
| Q1 2025 | -55,210 | Reduce 25.04% | 165,300 | $6.73 |
| Q4 2024 | +61,500 | Add 38.68% | 220,510 | $6.79 |
| Q3 2024 | -142,400 | Reduce 47.24% | 159,010 | $8.29 |
| Q2 2024 | +34,800 | Add 13.05% | 301,410 | $6.34 |
| Q1 2024 | +71,447 | Add 36.61% | 266,610 | $9.27 |
| Q4 2023 | +117,153 | Add 150.18% | 195,163 | $12.75 |
| Q3 2023 | -14,390 | Reduce 15.57% | 78,010 | $10.33 |
| Q2 2023 | -102,445 | Reduce 52.58% | 92,400 | $0.01 |
| Q1 2023 | +176,803 | Add 979.95% | 194,845 | $0.01 |
| Q4 2022 | +18,042 | New Buy | 18,042 | $0.01 |
| Q2 2022 | -81,600 | Sold Out | 0 | $0.00 |
| Q1 2022 | -71,700 | Reduce 46.77% | 81,600 | $24.80 |
| Q4 2021 | +63,200 | Add 70.14% | 153,300 | $32.07 |
| Q3 2021 | +61,800 | Add 218.37% | 90,100 | $35.98 |
| Q2 2021 | +28,300 | New Buy | 28,300 | $44.13 |
Renaissance Technologies (RenTech)'s Pulmonx Corporation Investment FAQs
Renaissance Technologies (RenTech) first purchased Pulmonx Corporation (LUNG) in Q2 2021, acquiring 28,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Pulmonx Corporation (LUNG) for 19 quarters since Q2 2021.
Renaissance Technologies (RenTech)'s largest addition to Pulmonx Corporation (LUNG) was in Q1 2023, adding 194,845 shares worth $2,178.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 320,300 shares of Pulmonx Corporation (LUNG), valued at approximately $413,187.
As of the Q1 2026 filing, Pulmonx Corporation (LUNG) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Pulmonx Corporation (LUNG) was 332,810 shares, as reported at the end of Q3 2025.